CERDELGA 84 mg, hard capsule 56 capsules
Active ingredients: Eliglustat tartrate, Eliglustat
Commercialized according to BDPMDispensing in France: Prescription only
Hard capsule56 capsulesorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- CERDELGA 84 mg, gélule
- Pharmaceutical form
- gélule
- Route of administration
- orale
- Presentation description
- 4 plaquette(s) PETG : polyéthyl.téréphtalate de glycol copolymère polyoléfinique aluminium polychlortrifluoroéthylène de 14 gélule(s)
- Marketing authorisation holder
- SANOFI (PAYS-BAS)
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 5 Jun 2015
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Prescribed by a hospital doctor
- Enhanced ANSM monitoring
- Yes
BDPM identifiers
CIS
61414553CIP73000878CIP133400930008782Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| TARTRATE D'ÉLIGLUSTATgélule | 100 mg · une gélule | SA |
| ÉLIGLUSTATgélule | 84,4 mg · une gélule | FT |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.